MedPath

Reactions to Warnings on Hookah Ads

Not Applicable
Completed
Conditions
Hookah Smoking
Reactions to Warnings
Registration Number
NCT03723616
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to help us better understand what kinds of waterpipe tobacco advertisements appeal to young adults as well as to help evaluate and create health warnings that can be placed on waterpipe tobacco advertisements to inform young adults of the risks associated with smoking hookah tobacco.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4721
Inclusion Criteria
  • Young adults who are susceptible to or who are current tobacco smokers (which is defined as at least once in the past month, and using hookah tobacco on at least a monthly basis).
  • Must have Internet access for Phase 1 and Phase 2 and have a Turkprime account.
  • English speaker
Exclusion Criteria
  • Anyone who is not susceptible to waterpipe tobacco smoking or is not a current waterpipe tobacco smoker
  • Anyone who does not have Internet access or a Turkprime account

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Attitudes toward Waterpipe Tobacco Smoking as Measured by Questionnaireup to 45 minutes
Intention to Try (for Susceptible Nonsmokers of Waterpipe Tobacco Smokers) or Quit (for Smokers of Waterpipe Tobacco) as Measured by Questionnaireup to 45 minutes
Worry about Harms as Measured by Questionnaireup to 45 minutes
Perceived Risk as Measured by Questionnaireup to 45 minutes
Secondary Outcome Measures
NameTimeMethod
Avoidance / Acceptance of Health Warnings as Measured by Eye Trackingup to one hour
Effectiveness of Health Warnings on a 1 to 7 scaleup to 45 minutes

1 = Not at all effective to 7 = A great deal effective

Trial Locations

Locations (1)

Duke University

🇺🇸

Durham, North Carolina, United States

Duke University
🇺🇸Durham, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.